Skip to content

Comparison of the Erector Spinae Plane Block Versus Intrathecal Morphine on Post-Cesarean Delivery Analgesia

Comparison of the Erector Spinae Plane Block Versus Intrathecal Morphine on Post-Cesarean Delivery Analgesia

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04256642
Acronym
ESPCS
Enrollment
160
Registered
2020-02-05
Start date
2020-02-29
Completion date
2023-01-31
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications

Brief summary

This study is a Randomized Control Trial comparing the Erector Spinae Plane Block with intrathecal morphine for post cesarean delivery analgesia.

Interventions

PROCEDUREErector Spinae Plane Block

A nerve block that injects local anesthetic in the Erector Spinae Plane

DRUGIntrathecal morphine

Intrathecal morphine at the time of spinal anesthesia

Sponsors

Thammasat University
CollaboratorOTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing scheduled Cesarean delivery

Exclusion criteria

* Patients with an ASA score greater than 3 * Allergies to study medications * Contraindications to neuraxial analgesia * Patients with chronic pain * Patients unable to communicate in the study language

Design outcomes

Primary

MeasureTime frameDescription
24 hour area under the curve pain scoresFirst 24 hourIt will be measured at 3 6 12 18 and 24 hours after the end of the cesarean delivery. This pain will be assessed by asking the patient to go from lying to sitting (or use incentive spirometry) and rated using a linear 10 cm visual analogue scale (VAS). The 24 hour pain VAS area under the curve (AUC) will be calculated using the trapezoid rule.

Secondary

MeasureTime frameDescription
Measurement of quality of recovery after cesarean deliveryFirst 24 hoursAt 24 hours the ObsQoR11, a validated instrument to measure the quality of recovery after cesarean delivery, will be administered to the patient
Nausea and vomitingFirst 24 hoursThe incidence of nausea and vomiting will be rated on a 10 cm VAS
Analgesic usageFirst 24 hoursThe cumulative use of opioids, expressed as morphine equivalents will be recorded at 24 hours.
PruritusFirst 24 hoursThe incidence of pruritus will be rated on a 10 cm VAS
Incidente of persistent surgical painThree monthsPatients will be contacted by telephone 3 months after the cesarean to assess the presence of chronic pain. This will be done using a modification of the brief pain inventory

Countries

Canada

Contacts

Primary ContactAlbert Moore, MD
albert.moore@mcgill.ca5149341934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026